home / stock / gikly / gikly news

GIKLY News and Press, Grifols SA Barcelona ADR From 08/14/18

Stock Information
Company Name: Grifols SA Barcelona ADR
Stock Symbol: GIKLY
Market: OTC
Website: grifols.com
Menu
GIKLY GIKLY Quote GIKLY Short GIKLY News GIKLY Articles GIKLY Message Board
Get GIKLY Alerts

News, Short Squeeze, Breakout and More Instantly...
GIKLY - Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System

BARCELONA, Spain , Aug. 14, 2018 /PRNewswire/ --   Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced that the U.S. Food and Drug Administration (...
GIKLY - Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays

BARCELONA, Spain , June 19, 2018 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, announced today that it has received approval from the U.S. Food...

GIKLY - Grifols (GIKLY) Investor Presentation - Slideshow

The following slide deck was published by Grifols Sa ADR in conjunction with this Read more ...

GIKLY - Grifols Launches a New Testing Service for Patients Treated with Daratumumab

BARCELONA, Spain , May 31, 2018 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the leading companies in the world in plasma-derived biological medicines and transfusion medicine, today announced it is adding a Daratumumab neutralization testing service to its...
GIKLY - Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents

BARCELONA, Spain , May 14, 2018 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative diagnostic solutions, today announced the expansion of its blood typing solutions portf...

GIKLY - Grifols donates over 25 million international units of blood clotting factor in 2017

BARCELONA, Spain , April 16, 2018 /PRNewswire/ -- Today, Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced it has donated over 25 million international units (IU) of blood clotting factor medicines over the last year. This donation is part of Grifols' commitment to prov...

GIKLY - Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018

BARCELONA, Spain , April 6, 2018 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2017 Annual Report on Form 20-F with the United States Securities and Exchange Commission ("SEC") on April 6, 2018 . Grifols' Annual Report o...
GIKLY - Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD"

BARCELONA, Spain , Feb. 28, 2018 /PRNewswire/ -- Grifols (MCE:GRF, MCE:GRF.P, and NASDAQ:GRFS), a leader in the production of plasma-derived medicines and in diagnostic and hospital solutions to improve people's health, is drawing attention to a rare condition, alpha 1 -antitrypsin d...

Previous 10 Next 10